New and Notable Evidence 2023
View this email in your browser
Trusted evidence. Informed decisions. Better health.

New and Notable Evidence | February 2023

Listing of articles does not imply recommendation.
Please forward this email to anyone you think would be interested in it!



Induced abortion among female students in higher education institutions in Ethiopia: A systematic review and meta-analysis.  [FREE FULL TEXT]
Kefale B, Damtie Y, Arefaynie M, Yalew M, Adane B, Dilnesa T, Zewdie S, Wasihun Y, Adane M.
PLoS One. 2023 Jan 20;18(1):e0280084.
DOI: 10.1371/journal.pone.0280084. PMID: 36662902 

Medical Abortion before Confirmed Intrauterine Pregnancy: A Systematic Review.
Brandell K, Reynolds-Wright JJ, Boerma C, Gibson G, Hognert H, Tuladhar H, Heikinheimo O, Cameron S, Gemzell-Danielsson K; VEMA Study Group.
Semin Reprod Med. 2023 Jan 10.
DOI: 10.1055/s-0042-1760117. PMID: 36626915

No-Test Medication Abortion: A Systematic Review.
Pearlman Shapiro M, Dethier D, Kahili-Heede M, Kaneshiro B.
Obstet Gynecol. 2023 Jan 1;141(1):23-34.
DOI: 10.1097/AOG.0000000000005016. PMID: 36701607

Understanding the experiences and needs of LGBTIQA+ individuals when accessing abortion care and pregnancy options counselling: a scoping review.
Bowler S, Vallury K, Sofija E.
BMJ Sex Reprod Health. 2023 Jan 12:bmjsrh-2022-201692.
DOI: 10.1136/bmjsrh-2022-201692. PMID: 36635070


Copper intrauterine device increases vaginal concentrations of inflammatory anaerobes and depletes lactobacilli compared to hormonal options in a randomized trial. [FREE FULL TEXT]
Brown BP, Feng C, Tanko RF, Jaumdally SZ, Bunjun R, Dabee S, Happel AU, Gasper M, Nyangahu DD, Onono M, Nair G, Palanee-Phillips T, Scoville CW, Heller K, Baeten JM, Bosinger SE, Burgener A, Passmore JS, Heffron R, Jaspan HB.
Nat Commun. 2023 Jan 30;14(1):499.
DOI: 10.1038/s41467-023-36002-4. PMID: 36717556

Development of an Intrauterine Device Releasing Both Indomethacin and Levonorgestrel During the First Months of Use: Pharmacokinetic Characterization in Healthy Women.
Hofmann BM, Ahola M, Fels LM, Klein S, Lindenthal B, Pihlaja J.
Clin Pharmacokinet. 2023 Jan;62(1):113-126.
DOI: 10.1007/s40262-022-01201-7. PMID: 36648744

Effectiveness of peer-led education interventions on contraceptive use, unmet need, and demand among adolescent girls in Gedeo Zone, South Ethiopia. A cluster randomized controlled trial. [FREE FULL TEXT]
Wondimagegene YA, Debelew GT, Koricha ZB.
Glob Health Action. 2023 Dec 31;16(1):2160543.
DOI: 10.1080/16549716.2022.2160543. PMID: 36695098 

Influence of Hormonal Contraceptive Use and HIV on Cervicovaginal Cytokines and Microbiota in Malawi.  [FREE FULL TEXT]
Haddad LB, Tang JH, Davis NL, Kourtis AP, Chinula L, Msika A, Tegha G, Hosseinipour MC, Nelson JAE, Hobbs MM, Gajer P, Ravel J, De Paris  mSphere. 2023 Jan 9:e0058522.
DOI: 10.1128/msphere.00585-22. PMID: 36622252 

Mediating effects of inequitable gender norms on intimate partner violence and contraceptive use in a cluster randomized control trial in Niger: A causal inference mediation analysis.  [FREE FULL TEXT]
Boyce SC, Minnis AM, Deardorff J, McCoy SI, Goin DE, Challa S, Johns NE, Aliou S, Brooks MI, Nouhou AM, Baker H, Silverman JG.
medRxiv. 2023 Jan 18:2023.01.12.23284504.
DOI: 10.1101/2023.01.12.23284504. PMID: 36711886 

Pharmacokinetics of dose-adjusted levonorgestrel emergency contraception combined with efavirenz-based antiretroviral therapy or rifampicin-containing tuberculosis regimens.  [FREE FULL TEXT]
Scarsi KK, Smeaton LM, Podany AT, Olefsky M, Woolley E, Barr E, Pham M, Mawlana S, Supparatpinyo K, Gatechompol S, Jalil EM, Gadama L, Badal-Faesen S, Belaunzaran-Zamudio PF, Godfrey C, Cohn SE, Mngqibisa R; AIDS Clinical Trials Group A5375 Study Team. Contraception. 2023 Jan 11:109951.
DOI: 10.1016/j.contraception.2023.109951. PMID: 36641094 

Contraceptive methods in adolescence: a narrative review of guidelines.
Margaritis K, Margioula-Siarkou G, Margioula-Siarkou C, Petousis S, Galli-Tsinopoulou A.
Eur J Contracept Reprod Health Care. 2023 Feb;28(1):51-57.
DOI: 10.1080/13625187.2022.2162336. PMID: 36637987 

Exploring the Role of Levonorgestrel Intrauterine System (LNG-IUS) as a Method of Emergency Contraception (EC).  [FREE FULL TEXT]
Kumari S, Sarkar A, Kulshreshtha A, Zangmo R, Roy KK.
Cureus. 2022 Nov 28;14(11):e31959.
DOI: 10.7759/cureus.31959. PMID: 36600871 

A five-year comparative study of efficacy and acceptability of three different sizes of TCu380Ag and TCu380A intrauterine devices.
Bhatla N, Sehgal R, Konar H, Vivekanand A, Kriplani A, Vanamail P, Purandare CN.
Int J Gynaecol Obstet. 2023 Jan 18.
DOI: 10.1002/ijgo.14651. PMID: 36652393

Interruptions in contraception and unintended pregnancy during the COVID-19 pandemic: A protocol for systematic review and meta-analysis.  [FREE FULL TEXT]
Geleto A, Taylor J, Beyene T.
Womens Health (Lond). 2023 Jan-Dec;19:17455057221147382.
DOI: 10.1177/17455057221147382. PMID: 36633116 

Investigating the risks of cardiovascular disease among premenopausal women using oral contraceptive: a protocol for a systematic review and meta-analysis. [FREE FULL TEXT]
Fabunmi OA, Dludla PV, Ngcobo SR, Nkambule BB.
BMJ Open. 2023 Jan 18;13(1):e071118.
DOI: 10.1136/bmjopen-2022-071118. PMID: 36657759 

Menstrual cup and risk of IUD expulsion - a systematic review.  [FREE FULL TEXT]
Bowman N, Thwaites A.
Contracept Reprod Med. 2023 Jan 21;8(1):15.
DOI: 10.1186/s40834-022-00203-x. PMID: 36670496 

Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.
Cohen MA, Edelman A, Paynter R, Henderson JT.
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908.
DOI: 10.1002/14651858.CD014908.pub2. PMID: 36622724 

Understanding women's views of and preferences for accessing postpartum contraception: a qualitative evidence synthesis.
Freeman-Spratt GJ, Botfield JR, Lee GS, Rajiv P, Black KI. 
BMJ Sex Reprod Health. 2023 Jan 12:bmjsrh-2022-201718.
DOI: 10.1136/bmjsrh-2022-201718. PMID: 36635069

Utilisation, effectiveness, and safety of immediate postpartum intrauterine device insertion: a systematic literature review.
Rosa Bolling K, Wahdan Y, Warnock N, Lott J, Schoendorf J, Pisa F, Gomez-Espinosa E, Kistler K, Maiese B.
BMJ Sex Reprod Health. 2022 Dec 9:bmjsrh-2022-201579.
DOI: 10.1136/bmjsrh-2022-201579. PMID: 36600467 

Venous thromboembolism associated with estrogen-containing contraceptives versus any hormonal risk factor: a comparison of recurrence rates.  [FREE FULL TEXT]
Wiegers HMG, Knijp J, van Es N, Coppens M, Klok FA, Middeldorp S, Moll S.
J Thromb Haemost. 2023 Jan;21(1):175-178.
DOI: 10.1016/j.jtha.2022.10.009. PMID: 36695380 

Family Planning 

Telehealth for Women's Preventive Services for Reproductive Health and Intimate Partner Violence: a Comparative Effectiveness Review.  [FREE FULL TEXT]
Cantor AG, Nelson HD, Pappas M, Atchison C, Hatch B, Huguet N, Flynn B, McDonagh M.
J Gen Intern Med. 2023 Jan 17:1-9.
DOI: 10.1007/s11606-023-08033-6. PMID: 36650334 

Use of healthcare resources and family planning methods 12 months after birth in women of South Auckland: The Healthy Mums and Babies (HUMBA) randomised trial.
Taylor RS, Wilson J, Li M, Culliney KAT, McCowan M, McKinlay C, McCowan LME, Okesene-Gafa K.
N Z Med J. 2022 Jan 20;136(1568):12-22.
PMID: 36657072 

Mapping evidence on postpartum modern family planning service uptake among women in Ethiopia: A scoping review.  [FREE FULL TEXT]
Cherie N, Abera M, Tura G.
Front Glob Womens Health. 2022 Dec 23;3:1043034.
DOI: 10.3389/fgwh.2022.1043034. PMID: 36619592 

Psychological interventions decrease unintended pregnancies: A meta-analysis of randomized controlled trials.
Swain LT, Malouff JM, Meynadier J, Schutte NS.
Br J Health Psychol. 2023 Jan 8.
DOI: 10.1111/bjhp.12641. PMID: 36617631

Reproductive health in transgender and gender diverse individuals: A narrative review to guide clinical care and international guidelines.  [FREE FULL TEXT]
Rodriguez-Wallberg K, Obedin-Maliver J, Taylor B, Van Mello N, Tilleman K, Nahata L.
Int J Transgend Health. 2022 Feb 14;24(1):7-25.
DOI: 10.1080/26895269.2022.2035883. PMID: 36713139 

Unintended pregnancies among HIV-positive women in sub-Saharan Africa: a scoping review protocol.  [FREE FULL TEXT]
Tomilola OR, Bolanle OE, Olufunmilayo OM.
Syst Rev. 2023 Jan 21;12(1):12.
DOI: 10.1186/s13643-023-02168-7. PMID: 36681857 

Unmet need for family planning among married women in sub-Saharan Africa: a meta-analysis of DHS data (1995 - 2020).  [FREE FULL TEXT]
Phiri M, Odimegwu C, Kalinda C.
Contracept Reprod Med. 2023 Jan 11;8(1):3.
DOI: 10.1186/s40834-022-00198-5. PMID: 36627720 

Methods Papers 

Assessing the Effect of Abortion Restrictions: Improving Methodology and Expanding Outcomes.
Darney BG, Boniface E, Liberty A.
Obstet Gynecol. 2023 Feb 1;141(2):233-235.
DOI: 10.1097/AOG.0000000000005062. PMID: 36649544 

Critiquing the Unintended Pregnancy Framework.
Auerbach SL, Coleman-Minahan K, Alspaugh A, Aztlan EA, Stern L, Simmonds K.
J Midwifery Womens Health. 2023 Jan 13.
DOI: 10.1111/jmwh.13457. PMID: 36637112 

New approaches for developing biomarkers of hormonal contraceptive use.
Sachdeva R, Kumar N, Brache V, Friedland BA, Plagianos M, Zhang S, Kizima L, Cochon L, Tabar AST, Blanc A, Merkatz RB.
Sci Rep. 2023 Jan 5;13(1):245.
DOI: 10.1038/s41598-022-24215-4.PMID: 36604469 


The efficacy of postpartum tubal sterilization training program with minilaparotomy approach in Ob/Gyn residents.  [FREE FULL TEXT]
Songkanha P, Chanprapaph P, Lertbunnaphong T, Supapueng O, Naimsiri U.
Heliyon. 2022 Dec 28;9(1):e12722.
DOI: 10.1016/j.heliyon.2022.e12722. PMID: 36632094 
Listing of articles does not imply recommendation. Please forward this email to anyone you think would be interested in it! New & Notable Evidence is a free monthly email service of the Cochrane Fertility Regulation Review Group
Keep up to date and subscribe here!
Copyright © 2023 Cochrane Fertility Regulation Group, All rights reserved.

unsubscribe from this list    update subscription preferences 

Please note: unsubscribing will remove you from the Cochrane Fertility Regulation Group's mailing list, but it will not automatically unsubscribe you from other Cochrane Groups' mailing lists or from Cochrane’s organizational mailing lists which you can manage at

Email Marketing Powered by Mailchimp